Institute of Enzymology, Research Centre for Natural Sciences of the Hungarian Academy of Sciences, Budapest, H-1117, Hungary.
Gene Design Kft., Szeged, H-6726, Hungary.
Nucleic Acids Res. 2018 Nov 2;46(19):10272-10285. doi: 10.1093/nar/gky815.
Cpf1s, the RNA-guided nucleases of the class II clustered regularly interspaced short palindromic repeats system require a short motive called protospacer adjacent motif (PAM) to be present next to the targeted sequence for their activity. The TTTV PAM sequence of As- and LbCpf1 nucleases is relatively rare in the genome of higher eukaryotic organisms. Here, we show that two other Cpf1 nucleases, Fn- and MbCpf1, which have been reported to utilize a shorter, more frequently occurring PAM sequence (TTN) when tested in vitro, carry out efficient genome modification in mammalian cells. We found that all four Cpf1 nucleases showed similar activities and TTTV PAM preferences. Our approach also revealed that besides their activities their PAM preferences are also target dependent. To increase the number of the available targets for Fn- and MbCpf1 we generated their RVR and RR mutants with altered PAM specificity and compared them to the wild-type and analogous As- and LbCpf1 variants. The mutants gained new PAM specificities but retained their activity on targets with TTTV PAMs, redefining RR-Cpf1's PAM-specificities as TTYV/TCCV, respectively. These variants may become versatile substitutes for wild-type Cpf1s by providing an expanded range of targets for genome engineering applications.
CPF1s 是 II 类聚类规则间隔短回文重复系统的 RNA 指导核酸内切酶,需要在靶序列旁边存在一个短的称为间隔基序(PAM)才能发挥活性。As 和 LbCPF1 核酸内切酶的 TTTV PAM 序列在高等真核生物的基因组中相对较少。在这里,我们表明,另外两种 Cpf1 核酸内切酶,Fn- 和 MbCpf1,在体外测试时被报道使用更短且更频繁出现的 PAM 序列(TTN),在哺乳动物细胞中进行有效的基因组修饰。我们发现,所有四种 Cpf1 核酸内切酶都表现出相似的活性和 TTTV PAM 偏好。我们的方法还揭示了除了它们的活性之外,它们的 PAM 偏好也是靶标依赖性的。为了增加 Fn- 和 MbCpf1 的可用靶标数量,我们生成了它们的 RVR 和 RR 突变体,改变了 PAM 特异性,并将它们与野生型和类似的 As- 和 LbCPF1 变体进行了比较。突变体获得了新的 PAM 特异性,但保留了对 TTTV PAMs 靶标的活性,分别重新定义了 RR-Cpf1 的 PAM 特异性为 TTYV/TCCV。这些变体可能成为野生型 Cpf1s 的多功能替代品,为基因组工程应用提供更广泛的靶标范围。